TAYLOR GLEN A purchased 634.8% of their position (18.75M shares) of ENVOY MEDICAL, INC. on the open market
Open‑market purchase worth $7.50M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/17/2026ACC: 0001104659-26-016182
+48.75M
Net shares
Net buyer
$7.50M
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
48.75M acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+18.75M
Price / share
$0.40
Trade value
$7.50M
% of position
634.8%
2/12/2026
2.95M→21.70M
Total
Net shares
+18.75M
Net value
$7.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/12/2026 | P · Purchase | +18.75M | $0.40 | $7.50M | 634.8% | 2.95M | 21.70M |
| Total | +18.75M | $7.50M | ||||||
Derivative Transactions2
Warrant Shares (Series A-1)
Direct
Converts to
Class A Common Stock
11.25M shares
Shares
+11.25M
Strike price
0.40
Held after
11.25M
Exercisable
—
2/12/2026
Warrant Shares (Series A-2)
Direct
Converts to
Class A Common Stock
18.75M shares
Shares
+18.75M
Strike price
0.40
Held after
18.75M
Exercisable
—
2/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant Shares (Series A-1) Direct | Class A Common Stock11.25M shares | 2/12/2026 | P · Purchase | +11.25M | 0.40 | — | 11.25M |
| Warrant Shares (Series A-2) Direct | Class A Common Stock18.75M shares | 2/12/2026 | P · Purchase | +18.75M | 0.40 | — | 18.75M |
Non-Derivative Holdings (Post-Transaction)2
Class A Common Stock
IndirectShares owned2.53M
Class A Common Stock
IndirectShares owned4.81M
Total
7.34M indirect7.34M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 2.53M | Indirect |
| Class A Common Stock | 4.81M | Indirect |
| Total | 7.34M | 7.34M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported